PTC Therapeutics :: Home

PTC is committed to bringing hope to patients with rare and genetic diseases.
Our scientists are finding new ways to regulate biology to control disease.
We are developing new treatments for Duchenne Muscular Dystrophy, Cystic Fibrosis and other diseases.

View Our Pipeline

Clinical Trials

PTC STRIVE Awards Program

Oct 04

Phase 2 Data from Spinal Muscular Atrophy Program Presented at the 20th International Annual Congress of the World Muscle Society

Oct 02

PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Sep 30

PTC Therapeutics Submits European Application For Translarna™ for Cystic Fibrosis

View all latest news

You are now leaving this website. If you would like to continue, click Continue.

Cancel Continue